 |
4-hydroxy-2,2,6,6-tetramethylpiperidine-N-oxyl |
|---|---|
| Trade Name | |
| Orphan Indication | Familial cerebral cavernous malformations |
| EU Market Approval | EU |
| EU Designation Date | 2017-12-12 00:00:00 |
| Sponsor | Premier Research Group Limited |
| |
4-hydroxy-2,2,6,6-tetramethylpiperidine-N-oxyl |
|---|---|
| Trade Name | |
| Orphan Indication | Familial cerebral cavernous malformations |
| EU Market Approval | EU |
| EU Designation Date | 2017-12-12 00:00:00 |
| Sponsor | Premier Research Group Limited |